213 results on '"Tong, Jiefei"'
Search Results
2. Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma
3. Tankyrase represses autoinflammation through the attenuation of TLR2 signaling
4. A Mutation in the Transmembrane/Luminal Domain of the Ryanodine Receptor Is Associated with Abnormal Ca 2+ Release Channel Function and Severe Central Core Disease
5. Data from CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration
6. Table S4 from CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration
7. Figure S4 from CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration
8. Supplementary Figure 2 from Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
9. Supplementary Data 2 from Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
10. Table S1 from Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
11. Supplementary Data 1 from Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
12. Data from Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
13. Supplementary Figure 1 from Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
14. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice
15. Data from ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma
16. Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer
17. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
18. Proteomic Characterization of a Candidate Polygenic Driver of Metabolism in Non-small Cell Lung Cancer
19. A Strategy for Modulation of Enzymes in the Ubiquitin System
20. Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors
21. Engineered SH2 Domains for Targeted Phosphoproteomics
22. Multiple Myeloma Phosphotyrosine Proteomic Profile Associated with FGFR3 Expression, Ligand Activation, and Drug Inhibition
23. A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway
24. Emerging applications for phospho-proteomics in cancer molecular therapeutics
25. Cancer proteome and metabolite changes linked to SHMT2
26. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
27. Serine-1321-independent regulation of the micro 1 adult skeletal muscle Na+ channel by protein kinase C
28. Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue
29. ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma
30. Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer
31. Evosep One Enables Robust Deep Proteome Coverage Using Tandem Mass Tags while Significantly Reducing Instrument Time
32. Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15
33. Evosep One Enables Robust Quantitative Deep Proteome Coverage using Tandem Mass Tags while Significantly Reducing Instrument Time
34. Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis
35. Non-driver somatic alteration burden confers good prognosis in non-small cell lung cancer
36. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis
37. The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation
38. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis
39. Integrated analysis of proteome, phosphotyrosine‐proteome, tyrosine‐kinome, and tyrosine‐phosphatome in acute myeloid leukemia
40. CCM-3 Promotes C. elegans Germline Development by Regulating Vesicle Trafficking Cytokinesis and Polarity
41. Protein-phosphotyrosine proteome profiling by superbinder-SH2 domain affinity purification mass spectrometry, sSH2-AP-MS
42. PUB052 Proteome Signatures and New Cancer Drivers
43. Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis.
44. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors
45. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2
46. Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers
47. Identification of human plasma cells with a lamprey monoclonal antibody
48. Abstract B2-01: Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact
49. Abstract A2-49: Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact
50. Abstract SY33-04: Integrated omic analysis of lung cancer reveals metabolism-proteome signatures with prognostic impact
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.